Results 201 to 210 of about 1,142,563 (307)

Further Insights Into Anticholinergic Action Informed by Japanese Anticholinergic Risk Scale

Geriatrics &Gerontology International, Volume 26, Issue 1, January 2026.
ABSTRACT The increased anticholinergic burden caused by medications in older adults is one of the adverse drug reactions of particular concern, as it can exacerbate the onset of geriatric syndromes or induce cognitive dysfunction, and is also related to the issue of polypharmacy.
Masaki Mogi, Shuang Liu, Yasuyuki Suzuki, Yuuka Shibata, Shizuo Yamada   +4 more
wiley   +1 more source

14-O-Heterocyclic-substituted naltrexone derivatives as non-peptide mu opioid receptor selective antagonists: Design, synthesis, and biological studies

, 2008
Li Guo, Lindsey C. Aschenbach, Hengjun He, Dana E. Selley, Yan Zhang   +4 more
openalex   +1 more source

Do patients with migraine and obesity receive different treatments? Insights from real‐world data

Headache: The Journal of Head and Face Pain, Volume 66, Issue 1, Page 88-95, January 2026.
Abstract Background Patients with obesity often experience stigma in healthcare, which may lead to underdiagnosis or undertreatment. In the context of pain management, and migraine specifically, patients with obesity are more likely to receive both opioid and non‐opioid analgesics.
Keshet Pardo, Maor Mermelstein, Gal Tsur, Shlomit Yust‐Katz   +3 more
wiley   +1 more source

Traumatic Brain Injury Induces Nociceptin/Orphanin FQ and Nociceptin Opioid Peptide Receptor Expression within 24 Hours. [PDF]

Int J Mol Sci
Al Yacoub ON, Zhang Y, Patankar PS, Standifer KM.   +3 more
europepmc   +1 more source

A synthetic peptide, derived from neurotoxin GsMTx4, acts as a non-opioid analgesic to alleviate mechanical and neuropathic pain through the TRPV4 channel

Shao-Xi Ke, Ping Dong, Yunqing Mei, J Wang, Mingxi Tang, Wan-xin Su, Jingjing Wang, Chen Chen, Xiaohui Wang, Junwei Ji, Xin-Ran ZHuang, Shuangshuang Yang, Yun Zhang, Linda M. Boland, Meng Cui, Masahiro Sokabe, Zhe Zhang, Qiong‐Yao Tang   +17 more
openalex   +1 more source

RELEASE OF OPIOID PEPTIDES IN ANAESTHETIZED CATS?

, 1980
Michael R. Dashwood, W. Feldberg
openalex   +2 more sources

A retrospective audit of the real‐world safety and effectiveness profile of eptinezumab for treatment‐resistant chronic migraine in Australia

Headache: The Journal of Head and Face Pain, Volume 66, Issue 1, Page 108-117, January 2026.
Abstract Objective To describe the real‐world safety, tolerability, and effectiveness of eptinezumab for chronic migraine prevention in Australia. Background Eptinezumab is a relatively new medication for treatment‐resistant chronic migraine prevention.
Lakshini Gunasekera, Shuli Cheng, Emma Foster, Shobi Sivathamboo, Terence O'Brien, Helmut Butzkueven, Jayashri Kulkarni, Elspeth Hutton   +7 more
wiley   +1 more source

Surface acoustic wave technology as a tool for functional characterization of new compounds [PDF]

, 2012
Bracke, Nathalie, Deneve, Laurens, De Spiegeleer, Bart   +2 more
core   +1 more source

Quercetin Alleviates Osteoarthritis Pain by Inhibiting Vascular Endothelial Growth Factor A Through Regulating cGAS/STING Pathway

Journal of Cellular and Molecular Medicine, Volume 30, Issue 1, January 2026.
ABSTRACT Knee osteoarthritis (KOA), a common degenerative joint disease marked by pain, inflammation and cartilage degradation, has been increasingly associated with dysregulated innate immune signalling. Among the implicated molecular pathways, cGAS/STING has emerged as a key modulator in both disease pathogenesis and therapeutic intervention ...
Enrui Hu, Yibao Wei, Taiyang Liao, Deren Liu, Zijian Gong, Jun Mao, Peimin Wang, Nongshan Zhang   +7 more
wiley   +1 more source

Specific receptor for the opioid peptide dynorphin: structure--activity relationships.

Proceedings of the National Academy of Sciences of the United States of America, 1981
C. Chavkin, A. Goldstein
semanticscholar   +1 more source